NCT06592196

Hepatic Safety of Statin Use in Neurology Inpatients

A Retrospective Study on the Hepatic Safety of Statin Use in Neurology Inpatients

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Shanghai Yueyang Integrated Medicine Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This research employs a cross-sectional study and a retrospective cohort study to analyze the liver safety of statin use among inpatients in the neurology department in China from different perspectives. The aim is to supplement evidence-based medicine and provide guidance for the clinical use of statins.

Conditions

• Statin Adverse Reaction

Interventions

Type	Name	Description
OTHER	stain	This research was conducted in two phases. Initially, a cross-sectional study was performed to assess the correlation between statin usage prior to hospital admission and the initial state of liver enzymes among patients. Subsequently, a retrospective cohort study was undertaken, wherein patients who had not been on statins prior to admission were categorized into two groups based on their statin usage post-admission.

Timeline

• Start date: 2024-08-10
• Primary completion: 2024-10-10
• Completion: 2024-12-10
• First posted: 2024-09-19
• Last updated: 2024-09-19

Locations

1 site across 1 country: China